![]() In recent years, Lilly has introduced multiple insulin affordability solutions that have made a real impact, including launching low-list-price, non-branded insulins in 2019, implementing the Lilly Insulin Value Program in 2020 and committing all of our insulins to the Medicare Part D Senior Savings Model in 2021. healthcare system that keep some people with diabetes from accessing affordable insulin. Today's announcement builds on years of efforts by Lilly to close the gaps in the U.S. We won't stop until all people with diabetes are in control of their disease and can get the insulin they need." Our work to discover new and better treatments is far from over. "For the past century, Lilly has focused on inventing new and improved insulins and other medicines that address the impact of diabetes and improve patient outcomes. We are calling on policymakers, employers and others to join us in making insulin more affordable," continued Ricks. ![]() "We are driving for change in repricing older insulins, but we know that 7 out of 10 Americans don't use Lilly insulin. People who don't have insurance can continue to go to and immediately download the Lilly Insulin Value Program savings card to receive Lilly insulins for $35 per month.Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.In addition to reducing the list price of its insulins, Lilly is making it easier for more people with diabetes to get Lilly insulins: Because these price cuts will take time for the insurance and pharmacy system to implement, we are taking the additional step to immediately cap out-of-pocket costs for patients who use Lilly insulin and are not covered by the recent Medicare Part D cap." "The aggressive price cuts we're announcing today should make a real difference for Americans with diabetes. "While the current healthcare system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone and that needs to change," said David A. ![]()
0 Comments
Leave a Reply. |